1-2 of 2
Elizabeth A. Kuczynski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1293: AZD0171 (anti-LIF) combines productively with chemotherapy and anti-PD-L1 in mouse models of cancer

Juliana Candido, Gozde Kar, Bairu Zhang, Grace Opoku-Ansah, Amit Grover, Elizabeth A. Kuczynski, Tim Slidel, Doug Palmer, Robert W. Wilkinsom, Nadia Luheshi, Jim Eyles
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1293.
https://doi.org/10.1158/1538-7445.AM2022-1293
Published: 15 June 2022
View article titled, Abstract 1293: AZD0171 (anti-LIF) combines productively with chemotherapy and anti-PD-L1 in mouse models of cancer
Journal Articles

Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma

Elizabeth A. Kuczynski, Christina R. Lee, Shan Man, Eric Chen, Robert S. Kerbel
Journal: Cancer Research
Cancer Res (2015) 75 (12): 2510–2519.
https://doi.org/10.1158/0008-5472.CAN-14-3687
Published: 14 June 2015
View article titled, Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma
Open the PDF for Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma in another window
Includes: Supplementary data